DeepRhythmAI vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepRhythmAI

by Medicalgorithmics

VX1

by Volta Medical

AI Verdict

DeepRhythmAI is designed for the accurate and efficient detection and classification of cardiac arrhythmias from ECG data, serving as a diagnostic aid for physicians. In contrast, VX1 provides real-time AI guidance to cardiac electrophysiologists during atrial fibrillation and atrial tachycardia ablation procedures, focusing on interventional support. While both are FDA-cleared AI tools in cardiology, their distinct applications target different phases of patient management and clinical workflows.

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-powered analysis of ECG data for comprehensive cardiac arrhythmia detection and classification across a broad patient population. This cloud-based, device-agnostic solution is ideal for health systems seeking to streamline diagnostic workflows, reduce missed diagnoses, and enhance overall cardiology department efficiency.

View DeepRhythmAI →

Choose VX1 if…

Choose VX1 if you are an electrophysiologist requiring real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures. This specialized software integrates directly with existing EP lab systems to assist in identifying dispersed electrograms, aiming to standardize outcomes and reduce inter-operator variability during complex cardiac interventions.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepRhythmAI	VX1
Pricing	Contact vendor for pricing information	Contact for pricing
Deployment	Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI's cloud-based and device-agnostic nature, coupled with API availability, offers broader integration and accessibility across various clinical settings for ECG analysis. While VX1 is described as user-friendly within its specialized EP lab environment, DeepRhythmAI's versatility provides a wider scope of usability for diverse healthcare providers.

Clinical Value

DeepRhythmAI

DeepRhythmAI provides strong, quantifiable claims of clinical value, including a significant reduction in missed diagnoses (14x to 114x fewer), and its clinical significance is well-established. While VX1 is FDA-cleared and assists in complex procedures, its clinical significance for improving ablation outcomes has not been established by clinical investigations, as noted in its FDA clearance documents.

Pricing & Value

Tie

Both tools have opaque pricing models, with DeepRhythmAI listed as 'enterprise' and VX1 requiring contact for pricing. Without specific pricing details or publicly available cost-benefit analyses for either product, it is impossible to definitively compare their value proposition.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI explicitly states compliance with multiple key healthcare and data security regulations, including HIPAA, GDPR, HITECH, SOC 2, and ISO 27001. It also offers flexible deployment models (SaaS, on-prem, hybrid) and targets a wide range of health systems, demonstrating a robust approach to enterprise integration and security.

Innovation

VX1

VX1 represents a significant innovation as the first FDA-cleared AI-based tool specifically designed for real-time assistance in interventional cardiac electrophysiology procedures. Its ability to analyze 3D anatomical and electrical maps during complex ablation procedures is a highly specialized and cutting-edge application of AI in cardiology.

Support & Docs

VX1

Volta Medical explicitly provides a 'VX1 SYSTEM USER MANUAL' and 'PDF Catalogs | Technical Documentation' for VX1, indicating readily available support resources. DeepRhythmAI's available information does not explicitly detail dedicated user manuals or support portals.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepRhythmAI	VX1
Name	DeepRhythmAI	VX1
Company	Medicalgorithmics S.A.	Volta Medical
Description	FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.	FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Primary Function	Cardiac arrhythmia detection and classification from ECG data	Real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Key Technology/Models	CNN and Transformer models, trained on 250 billion+ annotated heartbeats	AI-guided real-time identification of dispersed electrograms (EGMs), analyzes 3D anatomical and electrical maps
Target User/Specialty	Physicians (Cardiology)	Cardiac electrophysiologists (Cardiology)
API Available	yes	Not specified

Videos

Demos, reviews, and walkthroughs featuring DeepRhythmAI and VX1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of DeepRhythmAI versus VX1?

DeepRhythmAI is an FDA-cleared, cloud-based AI algorithm designed to revolutionize cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.

How do DeepRhythmAI and VX1 integrate into existing clinical environments?

DeepRhythmAI is a cloud-based software that is device-agnostic and integrates with various ECG devices, including Holter, event recorders, and mobile cardiac telemetry systems. VX1 is software integrated with existing electrophysiology (EP) lab mapping and recording systems and is compatible with most EP recording, 3D navigation systems, and mapping catheters.

Which medical specialties are the primary users for each tool?

DeepRhythmAI is primarily designed for physicians in cardiology, offering clinical decision support for arrhythmia diagnostics across solo practices to large health systems. VX1 is specifically tailored to assist cardiac electrophysiologists during AFib and atrial tachycardia ablation procedures.

What type of patient data does each AI tool analyze?

DeepRhythmAI analyzes ECG data, utilizing CNN and Transformer models trained on over 250 billion annotated heartbeats. VX1 analyzes 3D anatomical and electrical maps of human atria and provides cycle length estimation from electrograms during ablation procedures.

What are the key benefits each tool offers to a cardiology practice?

DeepRhythmAI offers faster ECG reporting and analysis, reduces missed diagnoses (14x to 114x fewer), and streamlines clinical workflows (up to 65% efficiency increase). VX1 is designed to reduce inter-operator variability, standardize outcomes during ablation procedures, and provides a booster mode for increased sensitivity during AT or slow AF.